Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 2
2011 4
2012 9
2013 11
2014 11
2015 14
2016 15
2017 12
2018 18
2019 27
2020 35
2021 38
2022 38
2023 35
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

251 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy of Carboplatin and Isotretinoin in Children With High-risk Medulloblastoma: A Randomized Clinical Trial From the Children's Oncology Group.
Leary SES, Packer RJ, Li Y, Billups CA, Smith KS, Jaju A, Heier L, Burger P, Walsh K, Han Y, Embry L, Hadley J, Kumar R, Michalski J, Hwang E, Gajjar A, Pollack IF, Fouladi M, Northcott PA, Olson JM. Leary SES, et al. Among authors: han y. JAMA Oncol. 2021 Sep 1;7(9):1313-1321. doi: 10.1001/jamaoncol.2021.2224. JAMA Oncol. 2021. PMID: 34292305 Free PMC article. Clinical Trial.
Application of oncolytic virus in tumor therapy.
Huang Z, Guo H, Lin L, Li S, Yang Y, Han Y, Huang W, Yang J. Huang Z, et al. Among authors: han y. J Med Virol. 2023 Apr;95(4):e28729. doi: 10.1002/jmv.28729. J Med Virol. 2023. PMID: 37185868 Review.
Children's Oncology Group Phase III Trial of Reduced-Dose and Reduced-Volume Radiotherapy With Chemotherapy for Newly Diagnosed Average-Risk Medulloblastoma.
Michalski JM, Janss AJ, Vezina LG, Smith KS, Billups CA, Burger PC, Embry LM, Cullen PL, Hardy KK, Pomeroy SL, Bass JK, Perkins SM, Merchant TE, Colte PD, Fitzgerald TJ, Booth TN, Cherlow JM, Muraszko KM, Hadley J, Kumar R, Han Y, Tarbell NJ, Fouladi M, Pollack IF, Packer RJ, Li Y, Gajjar A, Northcott PA. Michalski JM, et al. Among authors: han y. J Clin Oncol. 2021 Aug 20;39(24):2685-2697. doi: 10.1200/JCO.20.02730. Epub 2021 Jun 10. J Clin Oncol. 2021. PMID: 34110925 Free PMC article. Clinical Trial.
Review: imaging technologies for flow cytometry.
Han Y, Gu Y, Zhang AC, Lo YH. Han Y, et al. Lab Chip. 2016 Nov 29;16(24):4639-4647. doi: 10.1039/c6lc01063f. Lab Chip. 2016. PMID: 27830849 Free PMC article. Review.
Nanoscale β-TCP-Laden GelMA/PCL Composite Membrane for Guided Bone Regeneration.
Mahmoud AH, Han Y, Dal-Fabbro R, Daghrery A, Xu J, Kaigler D, Bhaduri SB, Malda J, Bottino MC. Mahmoud AH, et al. Among authors: han y. ACS Appl Mater Interfaces. 2023 Jul 12;15(27):32121-32135. doi: 10.1021/acsami.3c03059. Epub 2023 Jun 26. ACS Appl Mater Interfaces. 2023. PMID: 37364054
GelMA/TCP nanocomposite scaffold for vital pulp therapy.
Han Y, Dal-Fabbro R, Mahmoud AH, Rahimnejad M, Xu J, Castilho M, Dissanayaka WL, Bottino MC. Han Y, et al. Acta Biomater. 2024 Jan 1;173:495-508. doi: 10.1016/j.actbio.2023.11.005. Epub 2023 Nov 7. Acta Biomater. 2024. PMID: 37939819
251 results